Back

Heterozygous ABCC6 variant carriers are not at a higher risk for cardiovascular disease events than noncarriers

30 August 2026 (12:15 - 12:45)
Organised by: Logo
Congress Presentation Part of: What raises your risk of cardiovascular disease? Epidemiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Melanie Haverkamp

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Systemic anti-inflammatory therapy and risk of major adverse cardiovascular events in patients with psoriasis: a population-based cohort study
Doctor Y. Elizur (Tel Hashomer, IL)
Abstract
Presentation thumbnail
Monogenic familial hypercholesterolaemia confers excess premature cardiovascular risk beyond LDL-C: a family-lineage and LDL-C–matched analysis
Doctor J. Krefting (Munich, DE)
Abstract
Presentation thumbnail
Association of Cardiovascular-Kidney-Metabolic syndrome in young adulthood with subsequent major adverse cardiovascular events, all-cause mortality, and midlife Cardiovascular-Kidney -Metabolic stages
Doctor J. Wang (Shanghai, CN)
Abstract
Presentation thumbnail
Risk of in-hospital cardiovascular events according to type of respiratory viral infection: comparison between RSV, influenza and virus-negative patients
Doctor J. Perea (Buenos Aires, AR)
Abstract

Access the full session

Session thumbnail
What raises your risk of cardiovascular disease?

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Can variants of genes associated with familial heart block predict conduction disease in the general population? A UK Biobank study.
30 August 2024
thumbnail
Congress Presentation
Patients with pseudoxanthoma elasticum (PXE) do not have dyslipidemia
28 August 2022
thumbnail
Congress Presentation
CT-based cardiovascular risk stratification benefits in asymptomatic patients
9 May 2021
thumbnail
Congress Presentation
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources